Roger Garceau

Roger Garceau is a seasoned expert in global clinical development and regulatory affairs, particularly in the orphan drug sector. As the owner of RJG Consulting since February 2015, Garceau offers consulting services and currently serves on the board of directors for multiple organizations, including ArTara Therapeutics and Entera Bio Ltd. Garceau has held significant leadership positions, including Executive VP of Research & Development and Chief Medical Officer at NPS Pharmaceuticals, where oversight of R&D, medical affairs, and regulatory initiatives led to successful applications for two orphan products. Previous experience includes roles at sanofi-aventis managing new product marketing, medical communications, and clinical research. Garceau's educational background includes a Doctor of Medicine from UMass Chan Medical School and board certification in pediatrics.